Virpax Pharmaceuticals News

Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Aug 13 09:07 ET

Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2024 SECOND QUARTER RESULTS AND RECENT DEVELOPMENTS

Aug 13 07:37 ET

Virpax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 12 16:32 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 30 17:31 ET

Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Jul 29 16:37 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 26 16:34 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 24 07:49 ET

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Su Judy

Jul 15 18:44 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 15 08:04 ET

Virpax Pharmaceuticals | D: Filing D

Jul 12 16:03 ET

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Field Katharyn

Jul 10 16:16 ET

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Field Katharyn

Jul 10 16:16 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 10 12:49 ET

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Herman Gary L

Jul 9 16:06 ET

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder

Jul 9 16:06 ET

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Herman Gary L

Jul 9 16:06 ET

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Dhaliwal Jatinder

Jul 9 16:06 ET

Virpax Pharmaceuticals | DEFA14A: Others

Jul 8 16:38 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 8 07:32 ET

Virpax Pharmaceuticals | 8-K: Current report

Jul 3 17:06 ET